US Biotech Industry To India’s Modi: Follow Our IP Practices, Get ‘Tidal Wave’ Of Investment 13/01/2017 by William New, Intellectual Property Watch Leave a Comment US Biotechnology Innovation Organization CEO Jim Greenwood told Indian Prime Minister Narendra Modi this week if he follows western practices on intellectual property protection, his country would see a “tidal wave” of biotech industry investment.
After 15 Years In WTO, China Still Weak On Many IP Rights Rules, US Says 10/01/2017 by William New, Intellectual Property Watch Leave a Comment Innovation and intellectual property rights have set the United States apart from competitors in recent history, and China seems intent on closing that gap any way it can. A US trade office report out this week on China’s compliance with World Trade Organization rules 15 years after accession show the magnitude of China’s continuing compliance problems related to intellectual property rights.
Southeast Asian Countries Launch IP Cooperation Plan To Be Assisted By WIPO, EU 16/12/2016 by Sinfah Tunsarawuth for Intellectual Property Watch Leave a Comment BANGKOK – Countries in Southeast Asia have launched a 10-year action plan to strengthen their intellectual property rights cooperation, with the European Union and the World Intellectual Property Organization providing financial and technical assistance in helping the countries to achieve their goals.
In Search of Evidence: The IP Statistics For Decision Makers Conference (IPSDM) 2016 08/12/2016 by Guest contributor for Intellectual Property Watch Leave a Comment The annual “Intellectual Property Statistics for Decision Makers Conference” took place in Sydney, Australia on 15-16 November. After Vienna last year, the Organisation for Economic Co-operation and Development (OECD) as the key initiator organised the landmark forum this time with the Australian Government through its national intellectual property office, IP Australia. In this environment where the Australian economy could recently mark its 25 years of continuous growth and where the government just launched a new “National Innovation and Science Agenda” in the form of a new tax reform package, we could follow panel discussions and speeches about how empirical evidence can be gained for innovation.
TPP May Be Dead – But Its Impact Lingers 06/12/2016 by Intellectual Property Watch 3 Comments Despite the Trans-Pacific Partnership (TPP) being – to all-intents-and-purposes – dead in the water, pursuit of some of the most egregious objectives of the corporate interests driving the TPP agenda rolls on. Pharma is persisting in its push for countries to adopt not just TRIPS-Plus, but in some cases even TPP-Plus intellectual property rules – presumably groundwork for the later emergence of a ‘son-of-TPP’ agreement, three authors write.
Russia To Establish New IP Register For Military Equipment, Weapons 06/12/2016 by Eugene Gerden for Intellectual Property Watch 2 Comments A new register of intellectual property in the field of military and defence will soon be established in Russia in accordance with a recent decision of the national government, according to the state press service.
Hundreds Of Civil Society Groups Urge RCEP Negotiators To Reject Imported TPP Clauses 30/11/2016 by Intellectual Property Watch Leave a Comment As 16 Asia and Pacific nations prepare to meet in Indonesia next week for the next round of negotiations for a large regional trade agreement called RCEP, more than 300 civil society groups signed a letter urging negotiators to reject efforts to bring in texts from the separate Trans-Pacific Partnership (TPP).
Intellectual Property In Russia To Become Subject Of Antitrust Regulation 17/11/2016 by Eugene Gerden for Intellectual Property Watch Leave a Comment Intellectual property in Russia will become a subject of antitrust regulation starting next year, according to recent statements of an official spokesman of the Russian Federal Anti-Monopoly Service (FAS).
Indian Generic Pharma Warns Against Government Caving To US Pressure On Data Exclusivity 06/11/2016 by Catherine Saez, Intellectual Property Watch 3 Comments The Indian Drug Technical Advisory Board meeting on 7 November is expected to discuss a measure that could lead to opening the way to a 10-year data exclusivity period for originator pharmaceutical companies in India, according to the Indian Pharmaceutical Alliance. The alliance submitted a letter to the advisory board to warn against consequences on public health of data exclusivity if the Indian government “succumbs to” pressure by the United States.
More Rigorous Patent Examination In US Than Europe And Australia? 02/11/2016 by Intellectual Property Watch 3 Comments A recently published study finds that, contrary to a conventional view, the United States Patent and Trademark Office undertakes more rigorous patent examination than the European Patent Office and the Australian Patent Office.